# Landmark Bancorp Inc: financial statements, quarterly

LARK · Nasdaq · CIK 1141688 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lark.md) · [Financials](/companies/lark/financials.md) · [Filings](/companies/lark/filings.md) · [Insiders](/companies/lark/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lark/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [6,168](/filings/0001493152-23-040383.md) | [6,600 d](/filings/0001493152-24-011513.md) | [6,998](/filings/0001493152-24-019210.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [671](/filings/0001493152-24-045130.md) | [(111) d](/filings/0001493152-26-016495.md) | [518](/filings/0001641172-25-010303.md) | [587](/filings/0001641172-25-023507.md) | [867](/filings/0001493152-25-022251.md) | [(886) d](/filings/0001493152-26-016495.md) | [1,015](/filings/0001493152-26-021454.md) | [944](/filings/0001493152-26-037277.md) | [1,131](/filings/0001493152-25-022251.md) | [1,188 d](/filings/0001493152-26-016495.md) | [1,253](/filings/0001493152-26-021454.md) | [1,322](/filings/0001493152-26-037277.md) |
| Net income | $k | [2,878](/filings/0001493152-24-045130.md) | [2,639 d](/filings/0001493152-26-016495.md) | [2,778](/filings/0001641172-25-010303.md) | [3,012](/filings/0001641172-25-023507.md) | [3,931](/filings/0001493152-25-022251.md) | [3,282 d](/filings/0001493152-26-016495.md) | [4,701](/filings/0001493152-26-021454.md) | [4,404](/filings/0001493152-26-037277.md) | [4,930](/filings/0001493152-25-022251.md) | [4,740 d](/filings/0001493152-26-016495.md) | [5,066](/filings/0001493152-26-021454.md) | [5,392](/filings/0001493152-26-037277.md) |
| Diluted EPS | $ per share | [0.52](/filings/0001493152-24-045130.md) | not reported | [0.48](/filings/0001641172-25-010303.md) | [0.52](/filings/0001641172-25-023507.md) | [0.68](/filings/0001493152-25-022251.md) | not reported | [0.77](/filings/0001493152-26-021454.md) | [0.72](/filings/0001493152-26-037277.md) | [0.85](/filings/0001493152-25-022251.md) | not reported | [0.83](/filings/0001493152-26-021454.md) | [0.88](/filings/0001493152-26-037277.md) |
| Basic EPS | $ per share | [0.53](/filings/0001493152-24-045130.md) | not reported | [0.48](/filings/0001641172-25-010303.md) | [0.52](/filings/0001641172-25-023507.md) | [0.68](/filings/0001493152-25-022251.md) | not reported | [0.77](/filings/0001493152-26-021454.md) | [0.73](/filings/0001493152-26-037277.md) | [0.85](/filings/0001493152-25-022251.md) | not reported | [0.83](/filings/0001493152-26-021454.md) | [0.88](/filings/0001493152-26-037277.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,558](/filings/0001493152-23-040383.md) | [1,562](/filings/0001641172-25-000643.md) | [1,553](/filings/0001493152-24-019210.md) | [1,561](/filings/0001493152-24-031564.md) | [1,564](/filings/0001493152-24-045130.md) | [1,574](/filings/0001493152-26-016495.md) | [1,579](/filings/0001641172-25-010303.md) | [1,625](/filings/0001641172-25-023507.md) | [1,617](/filings/0001493152-25-022251.md) | [1,607](/filings/0001493152-26-037277.md) | [1,606](/filings/0001493152-26-021454.md) | [1,607](/filings/0001493152-26-037277.md) |
| Total liabilities | $m | [1,448](/filings/0001493152-23-040383.md) | [1,435](/filings/0001641172-25-000643.md) | [1,427](/filings/0001493152-24-019210.md) | [1,433](/filings/0001493152-24-031564.md) | [1,424](/filings/0001493152-24-045130.md) | [1,438](/filings/0001493152-26-016495.md) | [1,436](/filings/0001641172-25-010303.md) | [1,476](/filings/0001641172-25-023507.md) | [1,461](/filings/0001493152-25-022251.md) | [1,446](/filings/0001493152-26-037277.md) | [1,444](/filings/0001493152-26-021454.md) | [1,440](/filings/0001493152-26-037277.md) |
| Shareholders' equity | $m | [110](/filings/0001493152-24-045130.md) | [127](/filings/0001493152-26-016495.md) | [127](/filings/0001641172-25-023507.md) | [128](/filings/0001493152-25-022251.md) | [140](/filings/0001493152-25-022251.md) | [136](/filings/0001493152-26-037277.md) | [143](/filings/0001493152-26-037277.md) | [148](/filings/0001493152-26-037277.md) | [156](/filings/0001493152-25-022251.md) | [161](/filings/0001493152-26-037277.md) | [162](/filings/0001493152-26-037277.md) | [167](/filings/0001493152-26-037277.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.1 d](/filings/0001493152-24-045130.md) | [1.2 d](/filings/0001493152-26-016495.md) | [2.9](/filings/0001641172-25-010303.md) | [4.4 d](/filings/0001641172-25-023507.md) | [8.1 d](/filings/0001493152-25-022251.md) | [(1.1) d](/filings/0001493152-26-016495.md) | [8.0](/filings/0001493152-26-021454.md) | [0.4 d](/filings/0001493152-26-037277.md) | [10.3 d](/filings/0001493152-25-022251.md) | [2.9 d](/filings/0001493152-26-016495.md) | [6.8](/filings/0001493152-26-021454.md) | [3.4 d](/filings/0001493152-26-037277.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001493152-24-045130.md) | [0.5 d](/filings/0001493152-26-016495.md) | [1.3](/filings/0001641172-25-010303.md) | [0.6 d](/filings/0001641172-25-023507.md) | [0.3 d](/filings/0001493152-25-022251.md) | [0.1 d](/filings/0001493152-26-016495.md) | [0.0](/filings/0001493152-26-021454.md) | [0.1 d](/filings/0001493152-26-037277.md) | [0.3 d](/filings/0001493152-25-022251.md) | [0.2 d](/filings/0001493152-26-016495.md) | [0.1](/filings/0001493152-26-021454.md) | [0.1 d](/filings/0001493152-26-037277.md) |
| Dividends paid | $m | [1.1 d](/filings/0001493152-24-045130.md) | [1.1 d](/filings/0001493152-26-016495.md) | [1.1](/filings/0001641172-25-010303.md) | [1.2 d](/filings/0001641172-25-023507.md) | [1.2 d](/filings/0001493152-25-022251.md) | [1.2 d](/filings/0001493152-26-016495.md) | [1.2](/filings/0001493152-26-021454.md) | [1.2 d](/filings/0001493152-26-037277.md) | [1.2 d](/filings/0001493152-25-022251.md) | [1.2 d](/filings/0001493152-26-016495.md) | [1.3](/filings/0001493152-26-021454.md) | [1.3 d](/filings/0001493152-26-037277.md) |
| Share repurchases | $m | not reported | not reported | [0.2](/filings/0001641172-25-010303.md) | [0.1 d](/filings/0001641172-25-023507.md) | [0.1 d](/filings/0001493152-25-022251.md) | [0.0 d](/filings/0001493152-26-016495.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.2](/filings/0001493152-23-040383.md) | [5,482](/filings/0001493152-24-019210.md) | [5,481](/filings/0001493152-24-031564.md) | [5,483](/filings/0001493152-24-045130.md) | [5,749](/filings/0001641172-25-010303.md) | [5,748](/filings/0001641172-25-023507.md) | [5,771](/filings/0001493152-25-022251.md) | [6,105](/filings/0001493152-26-021454.md) | [6.1](/filings/0001493152-26-037277.md) | [5,830](/filings/0001493152-25-022251.md) | [6,139](/filings/0001493152-26-021454.md) | [6.2](/filings/0001493152-26-037277.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,100,534 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001493152-26-037277.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.